Comparative trial of two dosages of zalcitabine in zidovudine-experienced children with advanced human immunodeficiency virus disease. Pediatric AIDS Clinical Trials Group.

Spector, S A; Blanchard, S; Wara, D W; Oleske, J M; McIntosh, K; Hodes, D; Dankner, W M; Salgo, M; McNamara, J

Spector, S A; Blanchard, S; Wara, D W; Oleske, J M; McIntosh, K; Hodes, D; Dankner, W M; Salgo, M; McNamara, J.

Affiliation

Spector SA; University of California, San Diego, La Jolla, USA.

Pediatr Infect Dis J ; 16(6): 623-6, 1997 Jun.

Article in En | MEDLINE | ID: mdl-9194115

Subject(s)

Anti-HIV Agents/therapeutic use; HIV Infections/drug therapy; Zalcitabine/therapeutic use; Zidovudine/therapeutic use; Adolescent; Body Weight/drug effects; CD4 Lymphocyte Count/drug effects; Child; Child, Preschool; Female; HIV Core Protein p24/blood; Humans; Infant; Male

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Zidovudine / HIV Infections / Zalcitabine / Anti-HIV Agents Type of study: Clinical_trials Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Pediatr Infect Dis J Journal subject: DOENCAS TRANSMISSIVEIS / PEDIATRIA Year: 1997 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links